Anne-Claire Langlois

Anne-Claire Langlois
  • PharmD PhD
  • PostDoc Position at French Institute of Health and Medical Research

About

9
Publications
4,071
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
2,022
Citations
Current institution
French Institute of Health and Medical Research
Current position
  • PostDoc Position
Additional affiliations
October 2019 - December 2019
French Institute of Health and Medical Research
Position
  • PostDoc Position
October 2016 - September 2019
French Institute of Health and Medical Research
Position
  • PhD Student
February 2016 - July 2016
Institut Cochin
Position
  • Research Assistant
Education
October 2016 - September 2019
Sorbonne University
Field of study
  • Biology - Parasitology
September 2013 - September 2014
Sorbonne University
Field of study
  • Molecular and cellular biology
September 2007 - December 2014
Nantes Université
Field of study
  • Research/Industry

Publications

Publications (9)
Article
Full-text available
Plasmodium sporozoites are transmitted to a mammalian host during blood feeding by an infected mosquito and invade hepatocytes for initial replication of the parasite into thousands of erythrocyte-invasive merozoites. Here we report that the B9 protein, a member of the 6-cysteine domain protein family, is secreted from sporozoite micronemes and is...
Preprint
Plasmodium sporozoites are transmitted to a mammalian host during blood feeding by an infected mosquito and invade hepatocytes for initial replication of the parasite in the liver. This leads to the release of thousands of merozoites into the blood circulation and initiation of the pathogenic blood stages of malaria. Merozoite invasion of erythrocy...
Article
Full-text available
Sporozoite forms of the Plasmodium parasite, the causative agent of malaria, are transmitted by mosquitoes and first infect the liver for an initial round of replication before parasite proliferation in the blood. The molecular mechanisms involved during sporozoite invasion of hepatocytes remain poorly understood. Two receptors of the Hepatitis C v...
Preprint
Full-text available
Sporozoite forms of the malaria parasite Plasmodium are transmitted by mosquitoes and first infect the liver for an initial round of replication before parasite proliferation in the blood. The molecular mechanisms involved during sporozoite invasion of hepatocytes remain poorly understood. Two receptors of the Hepatitis C virus (HCV), the tetraspan...
Thesis
Full-text available
Les sporozoïtes de Plasmodium, l’agent du paludisme, sont transmis par les moustiques Anophèles et infectent le foie pour une première phase de réplication. Les mécanismes moléculaires impliqués dans l'invasion des hépatocytes restent méconnus. Deux récepteurs du virus de l'hépatite C (VHC), la tétraspanine CD81 et le récepteur Scavenger Receptor B...
Article
Full-text available
Sporozoite forms of the malaria parasite Plasmodium are transmitted by mosquitoes and first infect the liver for an initial round of replication before parasite proliferation in the blood. The molecular mechanisms involved during sporozoite invasion of hepatocytes remain poorly understood. In previous studies, two receptors of the Hepatitis C virus...
Data
Plasmodium EphA2 raw data set. This is the Excel file with the raw data (xlsx). (XLSX)
Article
Full-text available
Background In eukaryotic genomes, deletion or amplification rates have been estimated to be a thousand more frequent than single nucleotide variation. In Plasmodium falciparum, relatively few transcription factors have been identified, and the regulation of transcription is seemingly largely influenced by gene amplification events. Thus copy number...
Article
Full-text available
Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates...

Questions

Questions (2)
Question
Hi,
I'm currently trying to transfect transiently membrane receptors encoded by pcDNA3 plasmids in Hepa1-6 cell line using lipofectamine 3000. Despite my numerous adjustments (cell density/DNA quantity), i'm only getting 15 to 20 % of GFP expressing cells after immunostaining against my receptors and Flow cytometry.
I'm using the same protocol as thermofisher advise for this cell line.
I'm plating from a flask with non confluent cells, i transfect the next day on 90% confluent cells : 50 ng DNA/0,4microL of lipo300 and 0,1microL of P3000 + optimem per well (after mixing and incubation steps of course) for a final volume of 10microL mix added to 100microL of complete DMEM without ATB.
I saw no difference between a 24h or 48h incubation time in presence of the mix (I detach cells using cell dissociation buffer with EDTA). Moreover, I've been struggling with detection antibodies but i have two operational ones now.
If someone would have an idea to help me, it would be really nice :)
Side question : Is it mandatory to fix cells with formaldehyde after secondary antibody and before FACS ?
Thank you very much !
Anne-Claire
Question
Hi,
I'm currently trying to transfect transiently membrane receptors encoded by pcDNA3 plasmids in Hepa1-6 cell line using lipofectamine 3000. Despite my numerous adjustments (cell density/DNA quantity), i'm only getting 15 to 20 % of GFP expressing cells after immunostaining against my receptors and Flow cytometry.
I'm using the same protocol as thermofisher advise for this cell line.
I'm plating from a flask with non confluent cells, i transfect the next day on 90% confluent cells : 50 ng DNA/0,4microL of lipo300 and 0,1microL of P3000 + optimem per well (after mixing and incubation steps of course) for a final volume of 10microL mix added to 100microL of complete DMEM without ATB.
I saw no difference between a 24h or 48h incubation time in presence of the mix (I detach cells using cell dissociation buffer with EDTA). Moreover, I've been struggling with detection antibodies but i have two operational ones now.
If someone would have an idea to help me, it would be really nice :)
Side question : Is it mandatory to fix cells with formaldehyde after secondary antibody and before FACS ?
Thank you very much !
Anne-Claire

Network

Cited By